Fig. 1From: Real-world outcomes of PD-L1 inhibitors combined with thoracic radiotherapy in the first-line treatment of extensive stage small cell lung cancerPatient selection flowchart. ES-SCLC, extensive stage small cell lung cancer; PD-1, programmed cell death 1; PD-L1, programmed cell death ligand 1Back to article page